Literature DB >> 26855492

Hypoxia-Induced Inflammatory Chemokines in Subjects with a History of High-Altitude Pulmonary Edema.

K P Mishra1, Navita Sharma1, Poonam Soree1, R K Gupta1, Lilly Ganju1, S B Singh1.   

Abstract

High altitude hypoxia is known to induce an inflammatory response in immune cells. Hypoxia induced inflammatory chemokines may contribute to the development of high altitude pulmonary edema (HAPE) by causing damage to the lung endothelial cells and thereby capillary leakage. In the present study, we were interested to know whether chronic inflammation may contribute to HAPE susceptibility. We examined the serum levels of macrophage inflammatory protein-1α (MIP-1α), monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 in group (1) HAPE Susceptible subjects (n = 20) who had past history of HAPE and group (2) Control (n = 18) consist of subjects who had stayed at high altitude for 2 years without any history of HAPE. The data obtained confirmed that circulating MCP-1, MIP-1α were significantly upregulated in HAPE-S individuals as compared to the controls suggestive of chronic inflammation. However, it is not certain whether chronic inflammation is cause or consequence of previous episode of HAPE. The moderate systemic increase of these inflammatory markers may reflect considerable local inflammation. The existence of enhanced level of inflammatory chemokines found in this study support the hypothesis that subjects with past history of HAPE have higher baseline chronic inflammation which may contribute to HAPE susceptibility.

Entities:  

Keywords:  AMS; Chemokines; HAPE; Inflammation; SpO2

Year:  2015        PMID: 26855492      PMCID: PMC4731363          DOI: 10.1007/s12291-015-0491-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  36 in total

1.  High-altitude pulmonary edema. Characteristics of lung lavage fluid.

Authors:  R B Schoene; P H Hackett; W R Henderson; E H Sage; M Chow; R C Roach; W J Mills; T R Martin
Journal:  JAMA       Date:  1986-07-04       Impact factor: 56.272

2.  High-altitude pulmonary edema is initially caused by an increase in capillary pressure.

Authors:  M Maggiorini; C Mélot; S Pierre; F Pfeiffer; I Greve; C Sartori; M Lepori; M Hauser; U Scherrer; R Naeije
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

3.  Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor.

Authors:  Erik R Swenson; Marco Maggiorini; Stephen Mongovin; J Simon R Gibbs; Ilona Greve; Heimo Mairbäurl; Peter Bärtsch
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

4.  Modulation of immune response by the acute and chronic exposure to high altitude.

Authors:  Monica Facco; Chiara Zilli; Marta Siviero; Andrea Ermolao; Giuseppe Travain; Ilenia Baesso; Sondra Bonamico; Anna Cabrelle; Marco Zaccaria; Carlo Agostini
Journal:  Med Sci Sports Exerc       Date:  2005-05       Impact factor: 5.411

5.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

Authors:  P Ghezzi; C A Dinarello; M Bianchi; M E Rosandich; J E Repine; C W White
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

6.  Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface.

Authors:  R Shreeniwas; S Koga; M Karakurum; D Pinsky; E Kaiser; J Brett; B A Wolitzky; C Norton; J Plocinski; W Benjamin
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Molecular cloning and expression of the murine RANTES cytokine: structural and functional conservation between mouse and man.

Authors:  T J Schall; N J Simpson; J Y Mak
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

8.  The incidence, importance, and prophylaxis of acute mountain sickness.

Authors:  P H Hackett; D Rennie; H D Levine
Journal:  Lancet       Date:  1976-11-27       Impact factor: 79.321

9.  TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values.

Authors:  J L Herrmann; H Blanchard; P Brunengo; P H Lagrange
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

10.  RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.

Authors:  C M Lloyd; A W Minto; M E Dorf; A Proudfoot; T N Wells; D J Salant; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  5 in total

1.  Chemokines in High Altitude Pulmonary Edema.

Authors:  Srinivasa Bhattachar; Gaurav Sikri
Journal:  Indian J Clin Biochem       Date:  2016-05-27

2.  Andrographolide: Regulating the Master Regulator NF-κB.

Authors:  K P Mishra
Journal:  Indian J Clin Biochem       Date:  2019-12-10

3.  Subclinical pulmonary dysfunction contributes to high altitude pulmonary edema susceptibility in healthy non-mountaineers.

Authors:  Rajinder K Gupta; Poonam Soree; Koundinya Desiraju; Anurag Agrawal; Shashi Bala Singh
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

Review 4.  Bidirectional Crosstalk Between Hypoxia Inducible Factors and Glucocorticoid Signalling in Health and Disease.

Authors:  Tineke Vanderhaeghen; Rudi Beyaert; Claude Libert
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

5.  Deregulated hypoxic response in myeloid cells: A model for high-altitude pulmonary oedema (HAPE).

Authors:  Milos Gojkovic; Gabriella S Darmasaputra; Pedro Veliça; Helene Rundqvist; Randall S Johnson
Journal:  Acta Physiol (Oxf)       Date:  2020-03-16       Impact factor: 7.523

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.